The simultaneous control of hyperglycemia and GLP-1 infusion normalize endothelial function in type 1 diabetes

被引:8
|
作者
Ceriello, Antonio [1 ,2 ]
De Nigris, Valeria [1 ]
Pujadas, Gemma [1 ]
La Sala, Lucia [1 ,2 ,3 ]
Bonfigli, Anna Rita [4 ]
Testa, Roberto [5 ]
Uccellatore, Annachiara [3 ]
Genovese, Stefano [3 ]
机构
[1] IDIBAPS, C Rossello 149-153, Barcelona 08036, Spain
[2] Hosp Clin Barcelona, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain
[3] IRCCS Grp Multimed, Dept Cardiovasc & Metab Dis, Sesto San Giovanni, MI, Italy
[4] INRCA Ancona, Sci Direct, Ancona, Italy
[5] INRCA IRCCS Natl Inst, Expt Models Clin Pathol, Ancona, Italy
关键词
Type; 1; diabetes; GLP-1; Endothelial function; Oxidative stress; Metabolic memory; GLUCAGON-LIKE PEPTIDE-1; OXIDATIVE STRESS; DYSFUNCTION; VASODILATATION; ACTIVATION; MELLITUS; MARKERS; CELLS;
D O I
10.1016/j.diabres.2016.01.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To test the effect of normoglycemia and glucagon-like peptide-1 (GLP-1), alone or in combination, on the possible normalization of endothelial function in type 1 diabetes. Methods: Fifteen people with type 1 diabetes participated in three experiments: reaching and maintaining normoglycemia for 4 h; reaching and maintaining hyperglycemia plus GLP-1 infusion for 4 h; and reaching and maintaining normoglycemia for 4 h with simultaneous infusion of GLP-1. Results: Both normoglycemia and GLP-1 infusion restored endothelial function and decreased and plasma 8-iso prostaglandin F2 alpha levels. However, only the combination of normoglycemia and GLP-1 was able to normalize endothelial function. Conclusions: This study confirms that long-lasting hyperglycemia in type 1 diabetes induces a permanent alteration which contributes to maintaining endothelial dysfunction even when glycemia is normalized, and that in the presence of normoglycemia, GLP-1 can contribute to normalizing endothelial function. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:64 / 68
页数:5
相关论文
共 50 条
  • [41] Adjunct GLP-1 receptor agonist use in patients with Type 1 Diabetes
    Harkin, P.
    Crowley, R.
    McKenna, M.
    Canavan, R.
    Callanan, I
    Connolly, M.
    O'Shea, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S205 - S205
  • [42] GLP-1 agonist therapy in adolescents and young adults with type 1 diabetes
    Shacham, N.
    Ilkowitz, J.
    Stein, C.
    Gallagher, M. P.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 109 - 110
  • [43] Type 1 Diabetes Treatment Beyond Insulin: Role of GLP-1 Analogs
    Harrison, Lindsay B.
    Mora, Pablo F.
    Clark, Gregory O.
    Lingvay, Ildiko
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (01) : 40 - 44
  • [44] GLP-1 Receptor Agonists Models for Type 1 Diabetes: A Narrative Review
    Furio-Novejarque, Clara
    Diez, Jose-Luis
    Bondia, Jorge
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024,
  • [45] GLP-1 Receptor Agonists Models for Type 1 Diabetes: A Narrative Review
    Furio-Novejarque, Clara
    Diez, Jose-Luis
    Bondia, Jorge
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2025, 19 (02): : 332 - 339
  • [46] Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
    Unger, Jeff
    CURRENT DIABETES REPORTS, 2013, 13 (05) : 663 - 668
  • [47] Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
    Almohareb, Sumaya N.
    Alfayez, Osamah M.
    Aljuaid, Shoroq S.
    Alshahrani, Walaa A.
    Bakhsh, Ghalia
    Alshammari, Mohammed K.
    Al Yami, Majed S.
    Alshaya, Omar A.
    Alomran, Abdullah S.
    Korayem, Ghazwa B.
    Almohammed, Omar A.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [48] GLP-1 hypersecretion in gestational diabetes
    Fritsche, L.
    Heni, M.
    Eckstein, S. S.
    Winzenried, M. J.
    Hummel, J.
    Birkenfeld, A. L.
    Preissl, H.
    Haering, H. -U.
    Peter, A.
    Fritsche, A.
    Wagner, R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S44 - S45
  • [49] Indices of beta-cell function: association with diabetes control in patients with type 2 diabetes on stable GLP-1 agonist treatment
    Behary, Preeshila
    Godsland, Ian F.
    Baynes, Kevin C.
    PRACTICAL DIABETES, 2014, 31 (05) : 202 - 205
  • [50] GLP-1 Hypersecretion in Gestational Diabetes
    Fritsche, Louise
    Heni, Martin
    Eckstein, Sabine S.
    Winzenried, Maren J.
    Hummel, Julia
    Birkenfeld, Andreas L.
    Preissl, Hubert
    Haering, Hans-Ulrich
    Peter, Andreas
    Fritsche, Andreas
    Wagner, Robert
    DIABETES, 2020, 69